Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

ABIONYX Pharma - Filing #2821124

Concept 2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Reserve of exchange differences on translation
39,000 EUR
92,000 EUR
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
255,000 EUR
124,000 EUR
Current assets
10 033 EUR
10 125 EUR
Non-current liabilities
61,000 EUR
117,000 EUR
Current liabilities
3 598 EUR
3 466 EUR
Revenue
0 EUR
0 EUR
Profit (loss)
1 886 EUR
1 886 EUR
1 849 EUR
1 849 EUR
Comprehensive income
1 891 EUR
1 849 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.